Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate effects of a 16-week supplementation with a polyphenol rich extract, Sinetrol® Xpur, on fat mass accumulation and body weight management improvement.Subjects were overweight or obese and received polyphenol supplement or placebo. A 4-week follow-up as performed to evaluate its effect after supplementation stop.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of a Natural Ingredient on Obesity

NCT04105192

Overweight and Obesity High Blood Pressure

COMPLETED NA

Supplementation With Sirtuin Activators in Women With Increased Body Weight

NCT07245979

Obesity & Overweight

RECRUITING NA

Nutraceutical Supplement in the Management of Hypertension

NCT02663479

Hypertension

COMPLETED PHASE1/PHASE2

Effect of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight Individuals

NCT05758363

Overweight

COMPLETED NA

Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults

NCT05333315

Overweight and Obesity Inflammation Hypercholesterolemia +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Change in Total Body Fat Mass Percentage Loss Versus Body Weight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Verum

Sinetrol® Xpur

Group Type EXPERIMENTAL

Sinetrol® Xpur

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Sinetrol® Xpur

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* overweight or obese (25 kg.m-2\<BMI\<42.5kg.m-2)
* healthy

Exclusion Criteria

* metabolic or chronical disease with treatments (i.e.: diabetes, dyslipidemia, thyroiditis, inflammatory disease, immunological disease, infectious disease, asthma, anxiety and depression)
* food allergy to the ingredients of the product (grapefruit, orange, caffeine, guarana)
* involved in the prior 6 months in a chronic treatment program, eating disorders history, subjected to weight reduction by surgery
* start or quit smoking, high alcohol consumption
* pregnant, breastfeeding, wanting to have a baby,
* menopausal women

Minimum Eligible Age

25 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes